Patient-reported symptom burden under chemotherapy with fluorouracil

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022869

Enrollment

Registered

2020-09-24

Start date

2020-11-15

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Group 1: Patients with colorectal cancer are asked about their symptoms once a week for three months.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of colorectal cancer; ongoing or new treatment with fluorouracil; age = 18 years; electronic consent from the patient; sufficient knowledge of the German language

Exclusion criteria

Exclusion criteria: Patients who are physically and mentally not capable of independently completing the electronic patient questionnaire (e.g. due to dementia, Alzheimer's disease)

Design outcomes

Primary

Measure	Time frame
Symptom burden using PRO-CTCAE via a mobile, browser-compatible application, once a week for twelve weeks	—

Countries

Germany

Contacts

Public ContactEduard Schmulenson

Pharmazeutisches Institut, Rheinische Friedrich-Wilhelms-Universität Bonn

e.schmulenson@uni-bonn.de0228/735242

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026